#Novamind utah update
The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.Enhanced clinic enables greater access to ketamine and Spravato TM treatments Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. Important factors that could cause actual results to differ materially from the Company's expectations including the risks detailed from time to time in the Company's public disclosure. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. This news release contains forward-looking statements. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit Contact Information Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. For more information on the clinics, please visit our website. The Cedar Psychiatry clinic network has four locations in Utah, in Salt Lake City, Layton, Orem and Springville. "The enhanced clinic layout enables us to serve more clients with evidence-based treatments, including ketamine and future FDA approved psychedelics."Īs a leading provider of ketamine therapy in the United States, Cedar Psychiatry has administered over 4,000 ketamine sessions and over 1,700 Spravato TM treatments since its founding in 2016. Reid Robison, Chief Medical Officer and Director of Novamind. "The demand for mental health services continues to increase dramatically and we are responding by improving access to our most innovative treatments," said Dr. In 2020 alone, the Cedar Psychiatry clinic network facilitated over 20,000 client visits, an increase of over 100 percent compared to the same period in 2019. The Layton Clinic expansion comes in response to a significant increase in demand for ketamine therapies across Novamind's mental health clinics. The redesigned Layton Clinic now offers improved treatment rooms to accommodate a higher number of ketamine and Spravato TM (esketamine) treatments. (CSE:NM) ("Novamind" or the "Company"), a mental health company specialized in psychedelic medicine, announces the expansion and optimization of its Cedar Psychiatry clinic in Layton, Utah ("Layton Clinic"), the largest clinic in the Company's network. TORONTO, ON / ACCESSWIRE / Janu/ Novamind Inc. Enhanced clinic enables greater access to ketamine and Spravato TM treatments
0 kommentar(er)
